# Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers

> **NCT01440166** · PHASE1 · COMPLETED · sponsor: **Catabasis Pharmaceuticals** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Drug
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01440166
- **Lead sponsor:** Catabasis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2012-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01440166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01440166, "Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01440166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*